牛牛AI助理已提取核心訊息
On February 28, 2024, Pfizer Inc's Executive Vice President, Christoffel Boshoff, completed a transaction involving the company's common stock. Boshoff sold 4,150 shares at a price of $27.04 per share, resulting in a total market value of $112,216. The transaction was part of a payment for exercise price or tax liability by delivering or withholding securities. Additionally, Boshoff acquired 11,510 shares on the same date at no cost, which was reported as a grant, award, or other acquisition. Following these transactions, Boshoff directly holds 156,007 shares of Pfizer common stock. Separately, Boshoff also has an indirect beneficial ownership of 624 shares through a Rule 16b-3 Plan.
On February 28, 2024, Pfizer Inc's Executive Vice President, Christoffel Boshoff, completed a transaction involving the company's common stock. Boshoff sold 4,150 shares at a price of $27.04 per share, resulting in a total market value of $112,216. The transaction was part of a payment for exercise price or tax liability by delivering or withholding securities. Additionally, Boshoff acquired 11,510 shares on the same date at no cost, which was reported as a grant, award, or other acquisition. Following these transactions, Boshoff directly holds 156,007 shares of Pfizer common stock. Separately, Boshoff also has an indirect beneficial ownership of 624 shares through a Rule 16b-3 Plan.
2024年2月28日，輝瑞公司執行副總裁克里斯托弗爾·博肖夫完成了一項涉及公司普通股的交易。博肖夫以每股27.04美元的價格出售了4,150股股票，總市值爲112,216美元。該交易是通過交付或預扣證券支付行使價或納稅義務的一部分。此外，Boshoff於同日免費收購了11,510股股票，這被報告爲贈款、獎勵或其他收購。在這些交易之後，博肖夫直接持有輝瑞156,007股普通股。另外，通過第16b-3條計劃，博肖夫還擁有624股股票的間接實益所有權。
2024年2月28日，輝瑞公司執行副總裁克里斯托弗爾·博肖夫完成了一項涉及公司普通股的交易。博肖夫以每股27.04美元的價格出售了4,150股股票，總市值爲112,216美元。該交易是通過交付或預扣證券支付行使價或納稅義務的一部分。此外，Boshoff於同日免費收購了11,510股股票，這被報告爲贈款、獎勵或其他收購。在這些交易之後，博肖夫直接持有輝瑞156,007股普通股。另外，通過第16b-3條計劃，博肖夫還擁有624股股票的間接實益所有權。
有用
沒用